Jefferies profit more than doubles on strong dealmaking and equities

• Investment banking net revenues jumped 57.5% year-over-year to a record $1.21 billion, with advisory revenue surging 47% to $674.1 million on strong M&A activity including advising Sun Pharmaceutical and Kelonia Therapeutics deals
• Equity underwriting revenue more than tripled to $370.7 million, boosted by major IPOs and secondary offerings as private equity firms cashed out of portfolio companies
• Equities trading revenue rose 14% to a record $600.8 million while overall capital markets revenue increased 13.5% to $799.3 million, driven by market volatility prompting portfolio adjustments

Jefferies Q2 Profit Surges on Strong Investment Banking and Equities Performance

Key Financial Results:

Jefferies Financial Group reported that second-quarter profit more than doubled, driven by robust dealmaking and equity market activity. Investment banking net revenues jumped 57.5% year-over-year to a record $1.21 billion, while advisory revenue surged 47% to a record $674.1 million.

Equities Strength:

Equity underwriting revenue more than tripled to $370.7 million, with overall equities trading reaching a record $600.8 million (up 14%). The capital markets business generated $799.3 million in revenue, up 13.5% annually. Fixed income revenue grew 12%.

Market Context:

Global M&A volumes have exceeded $2.8 trillion in 2026, according to Dealogic, driven by technology, healthcare, and utility/energy sectors. Dealmaking has remained resilient despite geopolitical headwinds, with companies pursuing acquisitions for scale.

Notable Transactions:

Jefferies advised on several major deals including Sun Pharmaceutical's acquisition of Organon, Kelonia Therapeutics' sale for up to $7 billion, and served as joint global coordinator on a $6.3 billion IPO. The firm also participated as bookrunner on multiple large U.S. IPOs during the quarter.

Management Outlook:

CEO Richard Handler and President Brian Friedman expressed optimism about the second half of 2026, citing strong backlogs and new business bookings. They noted progress in building corporate M&A capabilities while maintaining strength in sponsor-led activity.

Market Implications:

Jefferies' results provide an early indicator of broader Wall Street investment banking trends ahead of major bank earnings. The stock has rallied recently, recovering losses after previous exposure to high-profile corporate collapses.